Pharmacology Dissertation Topics for 2026: Research Ideas and Guidance

Questions Students Ask When Choosing a Pharmacology Dissertation Topic

By the time you reach the topic-selection stage of a pharmacology degree, you already know the discipline. What you are usually wrestling with is something narrower and more practical:

• How do I turn a broad interest, such as drug safety or pharmacogenomics, into a question I can actually investigate with the data or laboratory access I have?
• Is my proposed topic realistic for a taught Master’s dissertation, or does it really need PhD-level resources?
• Should my dissertation be laboratory-based, or can it draw on clinical, epidemiological or database evidence instead?
• How specific does a pharmacokinetics or pharmacodynamics topic need to be before a supervisor will approve it?
• Where do I find a genuine gap, rather than repeating a question that has already been answered many times over?
• If I want to study something current, such as AI-assisted drug discovery or pharmacogenomic prescribing, how do I keep that topic researchable rather than speculative?

This article works through those questions by mapping the main research areas within pharmacology, explaining what separates a strong dissertation topic from a vague one, and providing a substantial set of pharmacology dissertation topics organised by subfield, along with guidance on academic level, methodology and current research direction.

What Makes a Strong Pharmacology Dissertation Topic

Pharmacology sits at the intersection of biomedical science, clinical practice and, increasingly, data science. That breadth is exactly why students often start too broad. “Antibiotic resistance” or “drug side effects” are subject areas, not dissertation topics.

A workable pharmacology dissertation topic should:

• Focus on a specific drug, drug class, mechanism, population or clinical context, rather than a whole therapeutic area
• Be answerable using evidence you can realistically access, whether that is laboratory work, a clinical dataset, a systematic review of published trials, prescribing databases, or survey data
• Sit clearly within a recognised subfield of pharmacology, such as pharmacokinetics, toxicology or pharmacoepidemiology, so your methodology and literature base are coherent
• Have a plausible route to a research question, not just a topic label
• Match the resources, ethical approvals and timeframe available at your academic level

Many strong pharmacology dissertations are built around published clinical trial data, prescribing databases, systematic reviews or secondary analysis of existing datasets, rather than original wet-lab experiments, which are rarely feasible within a standard taught dissertation timeframe. Knowing this in advance changes how you should scope your topic.

Key Research Areas in Pharmacology

Before settling on a specific topic, it helps to see the discipline in terms of its main research areas. Each of these represents a genuine subfield with its own literature, terminology and typical methodologies.

Clinical pharmacology examines how drugs are used in real patient care, including prescribing behaviour, polypharmacy, therapeutic drug monitoring and the role of clinical pharmacists.

Pharmacokinetics studies what the body does to a drug: absorption, distribution, metabolism and excretion (ADME), and how these processes vary between patient groups.

Pharmacodynamics studies what a drug does to the body, including receptor binding, dose-response relationships and mechanisms of therapeutic and adverse effect.

Drug discovery and development covers the identification, design and preclinical testing of new therapeutic compounds, including computational and AI-assisted approaches.

Pharmacogenomics and personalised medicine investigates how genetic variation affects individual drug response, metabolism and dosing requirements.

Toxicology and drug safety examines adverse drug reactions, medication errors, hepatotoxicity, cardiotoxicity and the systems used to detect and prevent harm.

Antimicrobial pharmacology focuses on antibiotic and antifungal mechanisms, resistance development and stewardship.

Neuropharmacology and cardiovascular pharmacology are two of the largest therapeutic-area subfields, covering drug mechanisms and clinical use within specific organ systems.

Pharmacoepidemiology and pharmacovigilance use population-level data to study prescribing trends, medication safety signals and real-world drug effectiveness.

Clinical trials methodology examines how drug development is tested and regulated, including trial design, patient recruitment and regulatory pathways.

Each of these areas can produce viable undergraduate, Master’s or PhD dissertations, but the scope and methodology you choose will look very different depending on which one you pick and how narrowly you define your question.

Pharmacology Dissertation Topics by Research Area

The topics below are organised by subfield and numbered continuously throughout the article. Each has been framed to identify a specific mechanism, drug class, population or clinical context, so that it can realistically develop into a dissertation proposal rather than remaining a broad subject label.

Clinical Pharmacology

1. Evaluating polypharmacy management strategies in elderly patients with multiple chronic conditions
2. Investigating prescribing patterns and rational drug use in UK primary care settings
3. Assessing the clinical impact of therapeutic drug monitoring for narrow therapeutic index medications
4. Examining deprescribing practices for long-term proton pump inhibitor use in older adults
5. Investigating clinician decision-making around off-label prescribing in paediatric populations
6. Evaluating the role of clinical pharmacists in reducing prescribing errors in hospital settings

Pharmacokinetics

7. Investigating the impact of renal impairment on the pharmacokinetics of commonly prescribed antibiotics
8. Assessing population pharmacokinetic modelling approaches for dose individualisation in obese patients
9. Examining age-related changes in drug absorption and metabolism in neonatal populations
10. Investigating drug-drug interactions affecting cytochrome P450 metabolism in patients on multiple medications
11. Assessing the pharmacokinetic profile of an extended-release formulation compared with its immediate-release equivalent
12. Investigating the influence of gut microbiota variation on oral drug bioavailability

Pharmacodynamics

13. Investigating receptor-binding mechanisms underlying tolerance to opioid analgesics
14. Examining dose-response relationships for a specific class of antihypertensive agents
15. Assessing biomarkers of pharmacodynamic response in anticoagulant therapy monitoring
16. Investigating mechanisms of drug resistance at the cellular receptor level in chemotherapy agents
17. Examining the pharmacodynamic basis of synergistic combinations in antibiotic therapy

Drug Discovery and Development

18. Investigating the application of artificial intelligence in early-stage drug candidate screening
19. Assessing structure-activity relationships in the design of novel antimicrobial compounds
20. Examining the translational challenges of moving preclinical drug candidates into early-phase clinical trials
21. Investigating the repurposing of existing licensed drugs for new therapeutic indications
22. Assessing the role of computational modelling in predicting drug toxicity during preclinical development
23. Investigating barriers to drug development for rare and neglected diseases
24. Examining organ-on-chip technology as an alternative to animal models in preclinical pharmacology

Pharmacogenomics and Personalised Medicine

25. Investigating the clinical implementation of pharmacogenomic testing in psychiatric prescribing
26. Assessing patient and clinician attitudes towards pharmacogenomic-guided prescribing in UK primary care
27. Examining genetic polymorphisms in drug-metabolising enzymes and their effect on statin response
28. Investigating the cost-effectiveness of pharmacogenomic screening prior to chemotherapy initiation
29. Assessing ethnic variation in CYP2D6 polymorphisms and its implications for antidepressant dosing
30. Investigating barriers to integrating pharmacogenomics into routine NHS clinical practice

Toxicology and Drug Safety

31. Investigating the incidence and preventability of adverse drug reactions in hospitalised elderly patients
32. Assessing the reliability of spontaneous adverse event reporting systems in pharmacovigilance
33. Examining hepatotoxicity risk factors associated with a specific class of medications
34. Investigating the toxicological profile of novel psychoactive substances
35. Assessing the effectiveness of enhanced monitoring schemes for newly licensed medicines
36. Investigating medication error patterns and contributing factors in community pharmacy dispensing
37. Examining long-term cardiovascular safety signals associated with a specific drug class

Antimicrobial Pharmacology and Resistance

38. Investigating antimicrobial stewardship programme effectiveness in reducing inappropriate antibiotic prescribing
39. Assessing mechanisms of bacterial resistance development to last-resort antibiotics
40. Examining the pharmacokinetic-pharmacodynamic relationship in optimising antibiotic dosing regimens
41. Investigating public understanding of antimicrobial resistance and its influence on patient expectations for antibiotics
42. Assessing the potential of bacteriophage therapy as an alternative to conventional antibiotics
43. Investigating antifungal resistance patterns in immunocompromised patient populations

Neuropharmacology

44. Investigating the pharmacological mechanisms underlying treatment-resistant depression
45. Assessing the efficacy and safety profile of novel anti-epileptic drug combinations
46. Examining neuroinflammatory pathways as therapeutic targets in neurodegenerative disease
47. Investigating the pharmacology of psychedelic-assisted therapy for treatment-resistant mental health conditions
48. Assessing withdrawal and dependence risks associated with long-term benzodiazepine prescribing

Cardiovascular Pharmacology

49. Investigating adherence patterns to guideline-directed medical therapy in heart failure management
50. Assessing comparative efficacy of novel oral anticoagulants versus warfarin in specific patient populations
51. Examining statin intolerance mechanisms and alternative lipid-lowering strategies
52. Investigating the cardiovascular safety profile of newer diabetes medications
53. Assessing pharmacological approaches to managing resistant hypertension

Pharmacoepidemiology and Pharmacovigilance

54. Investigating prescribing trends for a specific drug class using primary care databases
55. Assessing the association between a specific medication class and long-term adverse outcomes using cohort data
56. Examining the role of real-world evidence in post-marketing drug safety surveillance
57. Investigating medication adherence patterns and their determinants in chronic disease management
58. Assessing signal detection methods used in pharmacovigilance databases

Clinical Trials and Drug Development Methodology

59. Investigating the use of adaptive trial designs in accelerating drug development timelines
60. Assessing patient recruitment and retention challenges in early-phase oncology trials
61. Examining the representativeness of clinical trial populations relative to real-world patient demographics
62. Investigating regulatory pathways for accelerated approval of medicines for serious conditions
63. Assessing the ethical considerations of placebo-controlled trial design in vulnerable populations

If none of these pharmaceutical research topics matches your exact interest, the pharmaceuticals dissertation topics resource covers adjacent ground in drug manufacturing, regulation and industry practice, and the genetics dissertation topics page may be useful if your interest leans more towards the genetic mechanisms behind pharmacogenomics than the clinical application.

Matching Topics to Your Academic Level

Not every topic above suits every level of study. The same subject area can be narrowed or expanded depending on whether you are working towards an undergraduate, Master’s or PhD dissertation.

Undergraduate dissertations generally work best with a defined, manageable scope and accessible evidence. A systematic review of published literature on a specific drug interaction, or a survey-based study of patient or public attitudes (such as topic 41 on antimicrobial resistance awareness), is usually more realistic than a topic requiring clinical or genomic data access.

Master’s dissertations can support greater analytical depth and more sophisticated methodology. This is often the right level for topics involving secondary analysis of prescribing databases, comparative drug safety evaluation, or pharmacogenomic implementation studies (such as topics 26 or 30), where the student engages critically with existing evidence rather than simply summarising it.

PhD research should be capable of a more substantial and original contribution, whether that is generating new laboratory or clinical data, developing novel computational models, or producing a genuinely new synthesis of evidence in an underexplored area, such as bacteriophage therapy (topic 42) or organ-on-chip preclinical models (topic 24).

If you are unsure how to scope a topic to your level, narrowing the population, drug class, or outcome measure is usually the most effective adjustment, rather than changing the subject area altogether. The how to choose research topics guide covers this narrowing process in more general terms if you want a step back from pharmacology specifically.

Example Topics with Research Aims and Objectives

The following examples show how a topic from the list above can be developed into a clear research aim with supporting objectives. These are illustrations of structure, not templates to copy directly, since your own aim should reflect the specific evidence and context available to you.

Topic 26: Patient and clinician attitudes towards pharmacogenomic-guided prescribing in UK primary care

Research Aim: To investigate the attitudes of primary care clinicians and patients towards the use of pharmacogenomic testing in guiding antidepressant prescribing decisions.

Research Objectives:

1. To review current evidence on the clinical utility of pharmacogenomic testing in antidepressant selection.
2. To evaluate clinician confidence in interpreting and acting on pharmacogenomic test results.
3. To assess patient understanding of, and willingness to undergo, pharmacogenomic testing before starting antidepressant treatment.

Topic 38: Antimicrobial stewardship programme effectiveness

Research Aim: To evaluate the effectiveness of an antimicrobial stewardship programme in reducing inappropriate antibiotic prescribing within a hospital setting.

Research Objectives:

1. To analyse prescribing data before and after stewardship programme implementation.
2. To identify which intervention components were associated with the greatest reduction in inappropriate prescribing.
3. To assess clinician-reported barriers to adherence to stewardship recommendations.

Topic 49: Adherence to guideline-directed medical therapy in heart failure

Research Aim: To examine adherence patterns to guideline-directed pharmacological therapy among patients with chronic heart failure.

Research Objectives:

1. To determine the proportion of patients prescribed guideline-recommended medication classes at target doses.
2. To identify patient and prescriber-related factors associated with non-adherence to guideline-directed therapy.
3. To evaluate the relationship between adherence levels and hospital readmission rates.

Topic 18: Artificial intelligence in early-stage drug candidate screening

Research Aim: To assess the extent to which artificial intelligence tools improve the efficiency of early-stage drug candidate screening compared with traditional methods.

Research Objectives:

1. To review current AI-based approaches used in preclinical drug candidate identification.
2. To compare reported hit-rate and time-to-candidate metrics between AI-assisted and conventional screening pipelines.
3. To evaluate the limitations and validation challenges associated with AI-driven screening.

Topic 33: Hepatotoxicity risk factors

Research Aim: To investigate risk factors associated with hepatotoxicity in patients prescribed a specific class of medication over an extended treatment period.

Research Objectives:

1. To identify demographic and clinical factors associated with elevated hepatotoxicity risk in existing patient data.
2. To evaluate the effectiveness of current liver function monitoring protocols in detecting early hepatotoxicity.
3. To assess whether specific dosing patterns are associated with increased hepatotoxicity risk.

Methodology Considerations for Pharmacology Dissertations

The right methodology follows from your research question, not the other way round, but it helps to know what is realistically available at dissertation level.

Systematic and literature-based reviews are common for undergraduate and Master’s dissertations, particularly for topics involving drug safety comparisons, mechanism-of-action questions, or evaluating the strength of existing clinical trial evidence.

Secondary data analysis using prescribing databases, electronic health records or published trial datasets is often the most feasible route to a genuinely quantitative pharmacology dissertation without requiring laboratory access or new ethical approval for primary data collection.

Survey-based research works well for questions involving patient or clinician attitudes, such as topics on pharmacogenomic testing acceptance or antimicrobial resistance awareness.

Case study and clinical audit approaches can suit topics examining prescribing practice, medication error patterns or adherence to treatment guidelines within a specific clinical setting.

Computational and modelling approaches, including population pharmacokinetic modelling, are increasingly accessible to students with a quantitative background and suit topics involving dose individualisation or pharmacokinetic prediction.

Laboratory-based experimental work remains central to PhD-level pharmacology but is rarely practical for a standard taught dissertation timeframe unless you already have supervised access to a research laboratory.

Whichever approach you choose, make sure your research question is written clearly before you commit to a method. The how to write a research question guide is a useful reference point if you are still refining your question from one of the topics above.

Current Research Directions in Pharmacology for 2026

A few developments genuinely shape where pharmacology research is heading, and they are worth knowing if you want your dissertation to engage with current academic debate rather than simply attaching a year to an established topic.

Antimicrobial resistance remains one of the most active areas of pharmacological research globally, with growing academic and policy attention on stewardship, alternative therapies such as bacteriophages, and pharmacokinetic-pharmacodynamic optimisation of existing antibiotics. The World Health Organization continues to track resistance patterns and stewardship priorities, which is a useful evidence base for topics in this area.

Pharmacogenomics is moving from research interest towards clinical implementation, particularly in psychiatric and oncology prescribing, though genuine barriers around cost, clinician training and equitable access remain active and researchable debates rather than settled questions.

Artificial intelligence applications in drug discovery are expanding rapidly, but the evidence base on their real-world effectiveness compared with traditional screening methods is still developing, which makes this a genuinely open area for a critical dissertation rather than one with a settled answer.

Regulatory attention to real-world evidence and post-marketing surveillance continues to grow, reflected in ongoing work by bodies such as the Medicines and Healthcare products Regulatory Agency on adaptive licensing and safety monitoring, which is directly relevant to pharmacovigilance and pharmacoepidemiology topics.

None of this means older, more established pharmacology questions are less valuable. A well-executed dissertation on a long-standing prescribing safety issue is often more researchable, and just as academically respectable, than an ambitious topic built around a technology that is still too new to have a reliable evidence base.

Frequently Asked Questions

Conclusion

Choosing a pharmacology dissertation topic is less about finding an impressive-sounding subject and more about identifying a specific, evidenced question that you can realistically investigate within your timeframe and academic level. Use the research areas above to locate where your interest genuinely sits, whether that is pharmacokinetics, drug safety, pharmacogenomics or antimicrobial pharmacology, then narrow your chosen topic by drug class, population or outcome measure until it reads as a question rather than a subject. From there, checking data availability and matching your methodology to what is realistically accessible will do more to strengthen your dissertation than any amount of topic novelty.